BODE Index Calculator for COPD Prognosis
The BODE Index predicts survival in patients with chronic obstructive pulmonary disease (COPD). It combines four variables, Body mass index (B), airflow Obstruction measured by FEV1 (O), Dyspnea on the mMRC scale (D), and Exercise capacity from the 6-minute walk test (E), into a single 0-10 score. A higher score is associated with a greater risk of death. Enter your values below to get your BODE score, quartile, and the corresponding 4-year survival estimate from the original Celli et al. validation study.
Formula
Worked example
A COPD patient: BMI 22 kg/m² (>21, 0 pts), FEV1 55% predicted (50-64%, 1 pt), mMRC grade 2 (1 pt), 6MWT 300 m (250-349 m, 1 pt). BODE = 0+1+1+1 = 3. This falls in quartile 2 with approximately 67% 4-year survival.
What is the BODE Index?
The BODE Index is a multidimensional grading system for chronic obstructive pulmonary disease (COPD) that predicts the risk of death from any cause and from respiratory causes. It was developed and validated by Celli et al. and published in the New England Journal of Medicine in 2004. Unlike FEV1 alone, which only captures airflow obstruction, BODE integrates four independent predictors of mortality: body mass index (low BMI is associated with worse outcomes), the degree of airflow obstruction measured by FEV1 as a percentage of predicted, the severity of dyspnea on the modified Medical Research Council (mMRC) scale, and exercise capacity assessed by the 6-minute walk test. The acronym BODE comes from the first letter of each variable.
How to calculate the BODE Index
Each of the four variables is assigned 0-3 points according to standardized cut-offs, and the points are summed for a total of 0 to 10. BMI contributes 0 or 1 point: 0 if BMI is above 21 kg/m², 1 if BMI is 21 or below. FEV1 contributes 0-3 points: 0 if FEV1 is 65% predicted or higher, 1 for 50-64%, 2 for 36-49%, and 3 for 35% or below. The mMRC dyspnea scale contributes 0-3 points: 0 for grades 0 or 1 (breathless only with exertion or hurrying), 1 for grade 2 (walks slower than peers), 2 for grade 3 (stops after 100 m on level ground), and 3 for grade 4 (too breathless to leave the house). The 6-minute walk test (6MWT) contributes 0-3 points: 0 if the patient walks 350 m or more, 1 for 250-349 m, 2 for 150-249 m, and 3 for less than 150 m. The total BODE score is then mapped to one of four quartiles, each associated with a distinct 4-year survival probability.
How to interpret your BODE score
A score of 0-2 (quartile 1) corresponds to approximately 80% 4-year survival - the best prognosis group. A score of 3-4 (quartile 2) corresponds to approximately 67% 4-year survival. A score of 5-6 (quartile 3) corresponds to approximately 57% 4-year survival. A score of 7-10 (quartile 4) corresponds to approximately 18% 4-year survival, reflecting a very high mortality risk. These figures come from the original 2004 validation cohort and should be interpreted as group-level estimates, not individual predictions. Several interventions, notably pulmonary rehabilitation, long-term oxygen therapy in hypoxemic patients, and smoking cessation, can improve one or more components and thereby lower the BODE score over time.
Limitations and when not to use the BODE Index
The BODE Index is validated for stable COPD and should not be applied during or immediately after an acute exacerbation, as FEV1 and walk distance will be temporarily reduced. It is a prognostic tool only and does not guide specific therapeutic choices. The score works best in patients who can perform a reproducible spirometry test and a properly standardized 6-minute walk test, done on a flat surface with standardized encouragement. BODE was developed in patients with moderate-to-very-severe COPD; its accuracy at the very mild end (GOLD 1) is less well established. The 4-year survival figures are cohort averages from 2004: individual outcomes depend on comorbidities, exacerbation frequency, adherence to treatment, and many other factors not captured by the four BODE variables.
BODE Index scoring and 4-year survival
| BODE Score | Quartile | 4-Year Survival | Risk Level |
|---|---|---|---|
| 0-2 | Quartile 1 | ~80% | Low |
| 3-4 | Quartile 2 | ~67% | Moderate |
| 5-6 | Quartile 3 | ~57% | High |
| 7-10 | Quartile 4 | ~18% | Very High |
Scoring criteria and approximate 4-year all-cause survival from the original Celli et al. (2004) validation cohort.
Frequently asked questions
What does the BODE Index stand for?
BODE is an acronym for the four variables in the score: B for Body mass index, O for airflow Obstruction (measured by FEV1 % predicted), D for Dyspnea (rated on the mMRC scale), and E for Exercise capacity (measured by the 6-minute walk test). Each letter contributes up to 1-3 points, for a maximum total of 10.
What FEV1 value should I use?
Use the post-bronchodilator FEV1 expressed as a percentage of the predicted value for your age, sex, height, and ethnicity. This value comes from a spirometry report. If you have a pre-bronchodilator reading only, note that post-bronchodilator values are standard for COPD staging and the BODE score, so the result may differ slightly.
What is the mMRC Dyspnea Scale?
The Modified Medical Research Council (mMRC) dyspnea scale is a five-grade questionnaire. Grade 0: breathless only with strenuous exercise. Grade 1: short of breath when hurrying on the level or walking up a slight hill. Grade 2: walks slower than people of the same age on the level, or stops for breath when walking at own pace. Grade 3: stops for breath after walking about 100 meters or after a few minutes on level ground. Grade 4: too breathless to leave the house, or breathless when dressing. Grades 0 and 1 score 0 BODE points; grade 2 scores 1; grade 3 scores 2; grade 4 scores 3.
How is the 6-minute walk test performed?
The 6-minute walk test (6MWT) measures the distance a patient can walk on a flat, hard surface in 6 minutes. ATS guidelines call for a 30-meter corridor with turnaround cones, standardized encouragement, and rest if needed (though time continues). The test should not be performed during an acute exacerbation. Home estimates are unreliable; a properly supervised test in a clinic or hospital is needed for accurate BODE scoring.
Can the BODE score change over time?
Yes. Interventions can improve individual components. Pulmonary rehabilitation consistently increases 6-minute walk distance and reduces dyspnea, both of which lower the BODE score. Smoking cessation slows the FEV1 decline. Optimizing nutrition in underweight patients may improve BMI. Studies have shown that a decrease in BODE score after pulmonary rehabilitation is associated with improved survival, making serial measurements clinically useful.
Why does a low BMI increase the BODE score?
In COPD, low body weight reflects the systemic inflammatory burden and increased energy expenditure of labored breathing. Patients with COPD and a BMI of 21 or below have significantly worse survival than those with higher BMI, even when airflow obstruction is similar. This is the opposite of the general population, where obesity is the greater concern, and is why the BODE cut-off is set at BMI 21 rather than a higher value.
Is the BODE Index the same as GOLD staging?
No. GOLD (Global Initiative for Chronic Obstructive Lung Disease) staging classifies COPD severity based on FEV1 % predicted alone (GOLD 1-4). The BODE Index incorporates three additional predictors (BMI, dyspnea, exercise capacity) and has been shown to predict mortality better than FEV1 alone. GOLD staging guides treatment decisions, while the BODE Index primarily informs prognosis. Both are used together in clinical practice.
Sources
- Celli BR, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350:1005-1012.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report.